
COMMISSION REGULATION (EC) No 847/2000 of 27 April 2000 laying down the provisions for implementation of the criteria for designation of a medicinal product as an orphan medicinal product and definitions of the concepts ‘similar medicinal product’ and ‘clinical superiority’ (revoked) 
Purpose
Article 1 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Criteria for designation
Article 2 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Definitions
Article 3 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Entry into force
Article 4 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .